chronic gastritis
Conditions
Interventions
Sponsors
The Children's Hospital Zhejiang University Schoor Of Medicine
Eligibility
Sex/Gender
All
Age
5 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1. Gastroscopy is necessary due to illness; 2. In accordance with the diagnostic criteria of chronic gastritis and gastroscopic diagnosis basis in zhufutang Practical Pediatrics (8th Edition), the symptoms are recurrent and irregular abdominal pain. The pain often occurs in the process of eating or after meals, most of which are located in the upper abdomen and around the umbilicus, and some patients are not fixed. The mild ones are intermittent dull pain or dull pain, and the severe ones are severe colic. It is often accompanied by lack of appetite, nausea and vomiting Vomiting, abdominal distension, belching, acid reflux and heartburn; 3. The age is 5-14 years old and the gender is not limited; 4. Parents were informed and informed consent was signed after the subjects were included.
Exclusion criteria
Exclusion criteria: 1. Gastric ulcer and duodenal ulcer can be seen under gastroscope, and hematemesis and melena can be seen; 2. Those who need to use regular regimen combined with HP eradication therapy; 3. Allergic to drugs used in the study; 4. Other digestive system diseases and allergic diseases; 5. Liver and kidney function, routine blood, urine and feces, abnormal fecal occult blood have clinical significance; 6. Use of antibiotics, bismuth, acid making drugs and non steroidal anti-inflammatory drugs in recent one month; 7. Patients who have participated in other clinical studies or are participating in other clinical studies within 12 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The remission rate of abdominal pain in the fourth week of treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| The changes of clinical single symptom scores (abdominal pain, abdominal distension, nausea, vomiting, belching, acid regurgitation) compared with baseline at the fourth week of treatment; the total effective rate at the fourth week of treatment.; | — |
Countries
China
Contacts
Public ContactMizu Jiang
Outcome results
None listed